- American City Business Journals•12 hours ago
Regeneron Pharmaceuticals was ranked No. 3 on a list of the most innovative companies in the world by Forbes magazine. Regeneron is headquartered in Tarrytown, and the bulk of its manufacturing is done in East Greenbush. Driving Regeneron's growth has been sales of its multibillion-dollar macular degeneration medication Eylea, which went on the market four years ago.
- Zacks•13 hours ago
Acquisitions are back in focus in the biotech sector with Medivation (MDVN) agreeing to be acquired by Pfizer for $14 billion.
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||404.75 x 100|
|Ask||406.50 x 300|
|Day's Range||403.63 - 424.95|
|52wk Range||329.09 - 592.59|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||63.22|
|Avg Vol (3m)||830,079|
|Dividend & Yield||N/A (N/A)|